AWSIX
Price
$18.28
Change
+$0.08 (+0.44%)
Updated
Oct 8 closing price
Net Assets
641.86M
RWIBX
Price
$75.10
Change
+$0.48 (+0.64%)
Updated
Oct 8 closing price
Net Assets
141.87B
Interact to see
Advertisement

AWSIX vs RWIBX

Header iconAWSIX vs RWIBX Comparison
Open Charts AWSIX vs RWIBXBanner chart's image
Invesco Global Core Equity R5
Price$18.28
Change+$0.08 (+0.44%)
VolumeN/A
Net Assets641.86M
American Funds Capital World Gr&Inc R2
Price$75.10
Change+$0.48 (+0.64%)
VolumeN/A
Net Assets141.87B
AWSIX vs RWIBX Comparison Chart in %
View a ticker or compare two or three
VS
AWSIX vs. RWIBX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSIX is a Buy and RWIBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 142B vs. AWSIX (642M). AWSIX pays higher dividends than RWIBX: AWSIX (1.80) vs RWIBX (0.76). AWSIX was incepted earlier than RWIBX: AWSIX (20 years) vs RWIBX (23 years). RWIBX (1.51) is less costly to investors than AWSIX (0.97). AWSIX is a more actively managed with annual turnover of: 46.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than AWSIX: RWIBX (250) vs AWSIX (1000000). RWIBX annual gain was more profitable for investors over the last year : 11.86 vs. AWSIX (7.24). RWIBX return over 5 years is better than : 47.46 vs. AWSIX (15.42).
AWSIXRWIBXAWSIX / RWIBX
Total Expense Ratio0.971.5164%
Annual Report Gross Expense Ratio0.971.5164%
Fund Existence20 years23 years-
Gain YTD15.04420.70973%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets642M142B0%
Annual Yield % from dividends1.800.76237%
Returns for 1 year7.2411.8661%
Returns for 3 years60.6966.6791%
Returns for 5 years15.4247.4632%
Returns for 10 years42.4374.2757%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN21.360.36
+1.71%
Viridian Therapeutics
NYT55.270.41
+0.75%
New York Times Co
CUBWU10.57N/A
N/A
Lionheart Holdings
AMBI1.16-0.03
-2.52%
Ambipar Emergency Response
MAGN11.00-0.69
-5.90%
Magnera Corporation